PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference

<p>BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) &#8212; PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that it will be presenting at upcoming medical meetings and an investor conference. Ashling Holland, Director of Preclinical [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/pepgen-announces-presentations-at-the-2023-myotonic-dystrophy-foundation-annual-conference-ottawa-neuromuscular-disease-meeting-and-h-c-wainwright-25th-annual-global-investment-conference/">PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>